Tag Archives: COVID19

Payers saw volumes bounce back in Q3, say COVID-19 still volatile

In the third quarter, insurers saw a slight dampening from the record-high profits recorded in the previous quarter as medical utilization rebounded to about 95% of normal volumes for most major payers. They warned, however, that tailwinds may not last as people seek previously deferred care in the fourth quarter and into next year. Another… Read More »

New platform aims to unite the global health and care community during COVID-19

Health and social care consultancy group Meaningful Care Matters is launching a platform that aims to empower people through an international network of like-minded care communities.  The Meaningful Connections Community platform will offer individuals and care providers an opportunity to share, collaborate and debate issues impacting person-centred care cultures. To coincide with the platform’s launch… Read More »

Gilead’s Veklury becomes first FDA-approved drug for treating COVID-19

Dive Brief: The Food and Drug Administration has granted a full approval to Gilead’s COVID-19 drug Veklury, making it the first medicine to win a standard clearance from the agency to treat the disease caused by the new coronavirus. The FDA authorized Veklury for emergency use in May, a declaration that’s only valid during a… Read More »